U.S. Non Invasive Prenatal Testing Market To Expand US$ 2,557 Million by 2030

Posted by maria rai on February 25th, 2022

The Prominent Factors that are Expected to Contribute to the Growth of the United States Non-Invasive Prenatal Testing Market During the Forecast Period:

• increase in incidences of chromosomal aneuploidies among fetus
• progress of advanced non-invasive prenatal testing products
• rising adoption regarding non-invasive prenatal testing
• growing focus on reimbursement for non-invasive prenatal testing
• increasing preference for non-invasive techniques over invasive methods
• ACOG guidelines recommend NIPT for all pregnancies regardless of risk

The Key Market Players for the United States Non–Invasive Prenatal Testing Market are Listed Below:

• Illumina, Inc.
• Natera, Inc
• Quest Diagnostics
• Myriad Genetics, Inc.
• Centogene
• GenPath
• PerkinElmer
• Yourgene Health
• Invitae Corporation
• Agilent Technologies
• Ariosa Diagnostics (Roche)
• Laboratory Corporation of America Holdings

For More Information@ https://dpiresearch.com/us-non-invasive-prenatal-testing-nipt-2022-2030/

The report is readily available and can be dispatched immediately after payment confirmation.

Would like to place an order or any question, please feel free to contact at sales@dpiresearch.com

Customization of the Report:

DPI Research provides customization of the report as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

Contact Us:
Maria Rai
Head of Business Development
DPI Research
Direct Line: +91-766-764-8693
E-mail: sales@dpiresearch.com